Thyroid · 1998 · 67 citations · 14 references
MedicineOncologyCancer EpidemiologyCancer PreventionRenal PathologyBenign Thyroid DiseaseBladder CancerCancer RiskKidney CancerThyroid CancerThyroid DisordersCancer Risk AssessmentCancer Risk SurveillanceStandardized Incidence RatioThyroid Cancer Risk
The risk of cancer was examined in a cohort of 57,326 individuals who were discharged from a Danish hospital with a diagnosis of myxedema, thyrotoxicosis, or goiter. Although the general risk of cancer was only slightly increased, the risk of several sites was significantly above expected. The risk of thyroid cancer especially, was increased with standardized incidence ratios among women of 2.1 (myxedema), 2.5 (thyrotoxicosis), and 6.6 (nontoxic goiter). The increase in risk was present even many years after discharge, indicating that surveillance was not the only explanation. Furthermore, an increased risk was noted for cancer of the kidney in women discharged with myxedema (standardized incidence ratios [SIR] = 1.8) and thyrotoxicosis (SIR = 1.3), for cancer of the bladder in women discharged with myxedema (SIR = 1.5) and nontoxic goiter (SIR = 1.3), and for cancer of the hematopoetic system in women discharged with myxedema (SIR = 1.4) and nontoxic goiter (SIR = 1.4). The findings indicate that thyroid disorders may be related to cancer risk of several specific sites other than the thyroid.
14
Meyler's Side Effects of Drugs
A Breckenridge · BMJ · 1976 · 695 citations · Full text
A Population-Based Case-Control Study of Thyroid Cancer
Elaine Ron, Ruth A. Kleinerman, J. D. Boice et al. · JNCI Journal of the National Cancer Institute · 1987 · 345 citations
Medicine, Oncology, Cancer Control +16
Cancer Risk After Iodine-131 Therapy for Hyperthyroidism
Lars‐Erik Holm, Peter S Hall, K Wiklund et al. · JNCI Journal of the National Cancer Institute · 1991 · 269 citations
Medicine, Nuclear Medicine, Oncology +16